Investors / Frazier Life Sciences / Compare with Pivotal Life Sciences

Frazier Life Sciences vs Pivotal Life Sciences

Frazier Life Sciences lists 78 portfolio companies and has joined 17 funding rounds; Pivotal Life Sciences lists 33 companies and has joined 5 rounds. Frazier Life Sciences comes in most often at Growth (44% of its entries), Pivotal Life Sciences comes in most often at Series A (60% of its entries). 5 companies are on both portfolios, among them Arcutis, Crystalys Therapeutics and Parabilis Medicines.

Frazier Life SciencesView profilevsPivotal Life SciencesView profile

78Portfolio companies33

17Funding rounds joined5

6Rounds led1

11Rounds, last 12 months4

$100M or moreTypical round it comes in at$100M or more

0%Sites no longer answering0%

Show as a table

Frazier Life Sciences and Pivotal Life Sciences, head to head

	Frazier Life Sciences	Pivotal Life Sciences
Portfolio companies	78	33
Funding rounds joined	17	5
Rounds led	6	1
Rounds, last 12 months	11	4
Typical round it comes in at	$100M or more	$100M or more
Sites no longer answering	0%	0%

Companies both back

5

Arcutisarcutis.comCrystalys Therapeuticscrystalystx.comParabilis Medicinesparabilismed.comTrevi Therapeuticstrevitherapeutics.comVaxcytevaxcyte.com

Shared companies are those both firms' own portfolio pages list, each checked against the company's site. The same comparison through the API is POST /v1/overlap, for up to 20 firms. How the data is graded

$ curl -H "X-API-Key: YOUR_KEY" \
  https://api.vcinfo.io/v1/firms/frazierls.com/portfolio

# also
GET /v1/firms/pivotallifesciences.com/portfolio
GET /v1/firms/frazierls.com/coinvestors